Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/1996
07/09/1996US5534511 Aminoalkyl benzoxazolinones and benzothiazolinones
07/09/1996US5534253 Gentamycin
07/09/1996US5534240 Unchelated manganese composition for MRI of the gastrointestinal tract
07/09/1996US5533836 Compositions and methods for stimulating the growth of osteoblasts
07/09/1996CA2099381C Imidazopyridine paf/h _antagonists
07/04/1996WO1996020209A2 14α,17α-C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES
07/04/1996WO1996020207A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
07/04/1996WO1996020200A1 6-[triazolyl[3-(trifluoromethyl)phenyl]methyl]-2-quinolinones and -quinolinethiones
07/04/1996WO1996020194A1 Novel quinuclidine derivatives and medicinal composition thereof
07/04/1996WO1996020193A1 Compounds and methods
07/04/1996WO1996020190A1 Piperazine 2,5 dione derivatives as modulators of multi-drug resistance
07/04/1996WO1996020175A1 1,4,4-(trisubstituted)cyclohex-1-ene derivatives as pde iv- and tnf-inhibitors
07/04/1996WO1996020174A1 1,3,3-(trisubstituted)cyclohexane monomers and related compounds
07/04/1996WO1996020169A1 High purity n-(4-[n,n-bis(2-iodoethyl)amino]phenoscycarbonyl)-l-glutamic acid
07/04/1996WO1996020162A1 1,4,4-(trisubstituted)cyclohex-1-ene dimers and related compounds
07/04/1996WO1996020161A1 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds
07/04/1996WO1996020160A1 1,3,3-(trisubstituted)cyclohexane dimers and related compounds
07/04/1996WO1996020159A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
07/04/1996WO1996020157A1 3,3-(disubstituted)cyclohexan-1-ol dimers and related compounds
07/04/1996WO1996020156A1 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds
07/04/1996WO1996020153A1 4,4-(disubstituted)cyclohexan-1-one dimers and related compounds
07/04/1996WO1996019998A1 Bone mass anabolic composition comprising olpadronate
07/04/1996WO1996019997A1 Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception
07/04/1996WO1996019994A1 3,3-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds
07/04/1996WO1996019993A1 1,3,3-(trisubstituted)cyclohex-1-ene monomers and related compounds
07/04/1996WO1996019992A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
07/04/1996WO1996019990A1 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds
07/04/1996WO1996019988A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
07/04/1996WO1996019985A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
07/04/1996WO1996019984A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
07/04/1996WO1996019983A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
07/04/1996WO1996019980A1 3,3-(disubstituted)cyclohexan-1-one dimers and related compounds
07/04/1996WO1996019979A1 1,4,4-(trisubstituted)cyclohexane dimers and related compounds
07/04/1996WO1996019978A1 1,3,3-(trisubstituted)cyclohex-1-ene dimers and related compounds
07/04/1996WO1996019977A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds
07/04/1996WO1996011664A3 NSK2 a muscle receptor tyrosine kinase
07/04/1996WO1996003401A3 Process for the production of aminoazobicycloalkanes from oximes
07/04/1996DE4447599A1 Use of racemic or enantiomeric alpha liponic acid and derivs
07/04/1996DE4447401A1 14,17-C¶2¶-überbrückte Steroide 14,17-bridged C¶2¶-steroids
07/04/1996CA2208706A1 Mutants of the rb and p53 genes and uses thereof
07/04/1996CA2208445A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds
07/04/1996CA2208444A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
07/04/1996CA2208321A1 Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
07/04/1996CA2207500A1 Piperazine 2,5 dione derivatives as modulators of multi-drug resistance
07/04/1996CA2207268A1 6-¬triazolyl¬3-(trifluoromethyl)phenyl¦methyl¦-2-quinolinones and -quinolinethiones
07/04/1996CA2204741A1 High purity n-(4-[n,n-bis(2-iodoethyl)amino]phenoscycarbonyl)-l-glutamic acid
07/03/1996EP0719787A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
07/03/1996EP0719775A1 Substituted 4-phenyl thiazole derivatives, process for their preparation and pharmaceutical compositions containing them
07/03/1996EP0719770A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition
07/03/1996EP0719767A1 Succinamic acid compound, process for producing the same, and use thereof
07/03/1996EP0719764A1 3-Phenylisoquinolin-1 (2H)-one derivatives as GABA receptor ligands
07/03/1996EP0719558A1 Ranolazine and related piperazines for use in the treatment of shock conditions
07/03/1996EP0719554A1 Chondroprotective flavonoids
07/03/1996EP0719551A2 Isolating aminoarginine and use to block nitric oxide formation in body
07/03/1996EP0719549A1 Soft gelatine pharmaceutical dosage form containing a translucent gel
07/03/1996EP0719548A1 Gelling agent for polyethylene glycol
07/03/1996EP0719538A1 Skin external agent
07/03/1996EP0719285A1 Il8 inhibitors
07/03/1996EP0719283A1 Factor for fibroblast colony forming unit
07/03/1996EP0719278A1 Androstenone derivative
07/03/1996EP0719277A1 Androstenones
07/03/1996EP0719271A1 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
07/03/1996EP0719264A1 Imidazolone and oxazolone derivatives as dopamine antagonists
07/03/1996EP0719262A1 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxide-3-carboxylic acid derivatives, their preparation and drugs containing same
07/03/1996EP0719253A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists
07/03/1996EP0719252A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
07/03/1996EP0719156A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
07/03/1996EP0719152A1 Novel therapeutic and dietetic uses of a brain phospholipid-based complex
07/03/1996EP0719148A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
07/03/1996EP0719145A1 Nitric oxide donor composition and method for treatment of anal disorders
07/03/1996EP0719143A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
07/03/1996EP0719142A1 Pharmaceutical composition of hiv-protease inhibitors
07/03/1996EP0719140A1 Use of thiazolidinediones to prevent or delay onset of niddm
07/03/1996CN1125946A Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
07/03/1996CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors
07/03/1996CN1125942A Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors
07/03/1996CN1125941A Novel vitamin D analogues
07/03/1996CN1125601A Nourishing liquid for preserving vigour
07/03/1996CN1125581A Scorpion-and -ant oral liquid and its preparation method
07/03/1996CN1125575A Adhesion receptor antagonists
07/03/1996CN1032204C Process for preparing acetylenes disubstituted with phenyl group and heterobicyclic group having retinoid like activity
07/02/1996US5532387 Cyclization of trimethylhydroquinone and an alkenyl alcohol, reusable catalyst, iiib fluorosulfonate, nitrate, sulfate, or fluoroalkylsulfonate
07/02/1996US5532383 Leukotriene B4 antagonists
07/02/1996US5532375 Process for preparing 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oximes
07/02/1996US5532366 Enzyme inhibitors
07/02/1996US5532343 Purification and characterization of a glioma-derived growth factor having vascular endothelial cell growth promoting activity
07/02/1996US5532276 Angiotensin ii antagonists, hypotensive
07/02/1996US5532274 Levodopa, carbidopa, vinyl acetate-vinyl alcohol copolymer
07/02/1996US5532266 Treatment of hypoxia, antiedemic agents or antiinflammatory agents
07/02/1996US5532258 Antiulcer agents
07/02/1996US5532257 Benzothiazole compound, production thereof and use thereof
07/02/1996US5532255 Anticoagulants, cardiovascular disorders, antiinflammatory agents, arteriosclerosis or antitumor agents
07/02/1996US5532254 Modulation of calcium channels using benzothiophenes
07/02/1996US5532253 Enzyme inhibitors as anticoagulants
07/02/1996US5532245 To reduce smooth muscle contractions; treatment for urinary incontinence, iritable bowel syndrome
07/02/1996US5532242 Central nervous system cognition activators, anxiety and antidepressants
07/02/1996US5532241 Cns activity
07/02/1996US5532237 Intraocular for treatment of glaucoma
07/02/1996US5532227 Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive glycosylation of different types of collagen and other proteins during diabetes
07/02/1996US5532221 Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention
1 ... 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 ... 1564